Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients

Bone Marrow Transplantation

Volumn 26, Issue 7, 2000, Pages 759-762

  Jantunen, E ^a,b   Ruutu, P ^c   Piilonen, A ^a   Volin, L ^a   Parkkali, T ^a   Ruutu, T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Allogeneic BMT; Aspergillus infection; Outcome; Treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CORTICOSTEROID; CYCLOSPORIN A; FUNGUS ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; LUNG SURGERY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0033765074     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702604     Document Type: Article

References (32)

1. Aspergillus infections in bone marrow transplant recipients
2. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience
3. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: Results of a 5-year retrospective study
4. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
5. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
6. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
7. Invasive pulmonary aspergillosis: A diagnostic and therapeutic problem. Clinical experience with eight hematologic patients
8. An EORTC multi-centre prospective survey of invasive aspergillosis in haematological patients: Diagnostic and therapeutic outcome
9. Antifungal therapy in 'bone marrow failure'
10. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients
11. Favourable outcome of invasive aspergillosis in patients with acute leukemia
12. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
13. Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases
14. Therapeutic outcome of invasive aspergillosis
15. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer
16. Invasive pulmonary aspergillosis in acute leukemia. The contribution of early diagnosis and aggressive management
17. Invasive pulmonary aspergillosis. MRI, CT and plain radiographic findings and their contribution to early diagnosis
18. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening mycoses
19. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients
20. Amphotericin B: 30 years of clinical experience
21. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients
22. Invasive aspergillosis
23. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infection
24. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis
25. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies
26. Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: Report of eighteen cases
27. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic disease
28. Surgical therapy for pulmonary aspergillosis in immunocompromised patients
29. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor
30. Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients
31. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR
32. A polymerase chain reaction enzyme immunoassay for diagnosing infection caused by Aspergillus fumigatus